A role for inflammatory mediators in heterologous desensitization of CysLT1 receptor in human monocytes

Journal of Lipid Research

Volumn 51, Issue 5, 2010, Pages 1075-1084

  Capra, Valérie ^a   Accomazzo, Maria Rosa ^a   Gardoni, Fabrizio ^a   Barbieri, Silvia ^a   Rovati, G Enrico ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CYCLIC AMP; CYSTEINYL LEUKOTRIENE RECEPTOR 1; FORMYLPEPTIDE RECEPTOR; FORMYLPEPTIDE RECEPTOR LIKE 1; FORSKOLIN; G PROTEIN COUPLED RECEPTOR; HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H2 RECEPTOR; ISOPRENALINE; LEUKOTRIENE B4 RECEPTOR; LEUKOTRIENE D4; LEUKOTRIENE RECEPTOR; PEPTIDOLEUKOTRIENE; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; PROTEIN KINASE C; PURINERGIC P2Y2 RECEPTOR; PURINERGIC P2Y4 RECEPTOR; PURINERGIC P2Y6 RECEPTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DESENSITIZATION; ENZYME ACTIVATION; HETEROLOGOUS EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 77951066380     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M003236     Document Type: Article

References (52)

1. Samuelsson, B. 1983. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science. 220: 568-575. (Pubitemid 13130140)
2. Brink, C., S. E. Dahlen, J. Drazen, J. F. Evans, D. W. Hay, S. Nicosia, C. N. Serhan, T. Shimizu, and T. Yokomizo. 2003. International Union of Pharmacology XXXVII. Nomenclature for leukotriene and lipoxin receptors. Pharmacol. Rev. 55: 195-227. (Pubitemid 36268403)
3. Capra, V., M. D. Thompson, A. Sala, D. E. Cole, G. Folco, and G. E. Rovati. 2007. Cysteinyl-leukotrienes and their receptors in asthma and other inflammatory diseases: critical update and emerging trends. Med. Res. Rev. 27: 469-527. (Pubitemid 46984658)
4. Funk, C. D. 2005. Leukotriene modifiers as potential therapeutics for cardiovascular disease. Nat. Rev. Drug Discov. 4: 664-672. (Pubitemid 41149760)
5. Capra, V., M. Ambrosio, G. Riccioni, and G. E. Rovati. 2006. Cysteinyl-leukotriene receptor antagonists: present situation and future opportunities. Curr. Med. Chem. 13: 3213-3226. (Pubitemid 44680865)
6. Riccioni, G., V. Capra, N. D'Orazio, T. Bucciarelli, and L. A. Bazzano. 2008. Leukotriene modifiers in the treatment of cardiovascular diseases. J. Leukoc. Biol. 84: 1374-1378. (Pubitemid 352774472)
7. Fredriksson, R., M. C. Lagerstrom, L. G. Lundin, and H. B. Schioth. 2003. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol. Pharmacol. 63: 1256-1272. (Pubitemid 36627220)
8. Ciana, P., M. Fumagalli, M. L. Trincavelli, C. Verderio, P. Rosa, D. Lecca, S. Ferrario, C. Parravicini, V. Capra, P. Gelosa, et al. 2006. The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl- leukotrienes receptor. EMBO J. 25: 4615-4627. (Pubitemid 44498134)
9. Austen, K. F., A. Maekawa, Y. Kanaoka, and J. A. Boyce. 2009. The leukotriene E 4 puzzle: finding the missing pieces and revealing the pathobiologic implications. J. Allergy Clin. Immunol. 124: 406-414
10. Jiang, Y., L. A. Borrelli, Y. Kanaoka, B. J. Bacskai, and J. A. Boyce. 2007. CysLT2 receptors interact with CysLT1 receptors and down-modulate cysteinyl leukotriene-dependent mitogenic responses of mast cells. Blood. 110: 3263-3270 (Pubitemid 350106319)
11. Selbie, L. A., and S. J. Hill. 1998. G protein-coupled-receptor cross-talk: the fine-tuning of multiple receptor-signalling pathways. Trends Pharmacol. Sci. 19: 87-93.
12. Werry, T. D., G. F. Wilkinson, and G. B. Willars. 2003. Mechanisms of cross-talk between G-protein-coupled receptors resulting in enhanced release of intracellular Ca2+. Biochem. J. 374: 281-296.
13. Ali, H., R. M. Richardson, B. Haribabu, and R. Snyderman. 1999. Chemoattractant receptor cross-desensitization. J. Biol. Chem. 274: 6027-6030.
14. Walsh, M. T., J. F. Foley, and B. T. Kinsella. 2000. The alpha, but not the beta, isoform of the human thromboxane A2 receptor is a target for prostacyclin-mediated desensitization. J. Biol. Chem. 275: 20412-20423.
15. Steele, A. D., I. Szabo, F. Bednar, and T. J. Rogers. 2002. Interactions between opioid and chemokine receptors: heterologous desensitization. Cytokine Growth Factor Rev. 13: 209-222. (Pubitemid 34693175)
16. Capra, V., S. Ravasi, M. R. Accomazzo, S. Citro, M. Grimoldi, M. P. Abbracchio, and G. E. Rovati. 2005. CysLT1 receptor is a target for extracellular nucleotide-induced heterologous desensitization: a possible feedback mechanism in inflammation. J. Cell Sci. 118: 5625-5636.
17. Chuang, T. T., L. Iacovelli, M. Sallese, and A. De Blasi. 1996. G protein-coupled receptors: heterologous regulation of homologous desensitization and its implications. Trends Pharmacol. Sci. 17: 416-421.
18. Freedman, N. J., and R. J. Lefkowitz. 1996. Desensitization of G protein-coupled receptors. Recent Prog. Horm. Res. 51: 319-351; discussion 352-353.
19. Stout, R. D., and J. Suttles. 2004. Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J. Leukoc. Biol. 76: 509-513.
20. Gordon, S. 2003. Alternative activation of macrophages. Nat. Rev. Immunol. 3: 23-35.
21. Woszczek, G., R. Pawliczak, H. Y. Qi, S. Nagineni, S. Alsaaty, C. Logun, and J. H. Shelhamer. 2005. Functional characterization of human cysteinyl leukotriene 1 receptor gene structure. J. Immunol. 175: 5152-5159.
22. Ichiyama, T., M. Hasegawa, Y. Ueno, H. Makata, T. Matsubara, and S. Furukawa. 2005. Cysteinyl leukotrienes induce monocyte chemoattractant protein 1 in human monocytes/macrophages. Clin. Exp. Allergy. 35: 1214-1219. (Pubitemid 43919468)
23. Choudhury, R. P., J. M. Lee, and D. R. Greaves. 2005. Mechanisms of disease: macrophage-derived foam cells emerging as therapeutic targets in atherosclerosis. Nat. Clin. Pract. Cardiovasc. Med. 2: 309-315.
24. Mueller, C. F., K. Wassmann, J. D. Widder, S. Wassmann, C. H. Chen, B. Keuler, A. Kudin, W. S. Kunz, and G. Nickenig. 2008. Multidrug resistance protein-1 affects oxidative stress, endothelial dysfunction, and atherogenesis via leukotriene C4 export. Circulation. 117: 2912-2918.
25. Kilfeather, S. 2002. 5-lipoxygenase inhibitors for the treatment of COPD. Chest. 121: 197S-200S.
26. Biswas, S. K., A. Sica, and C. E. Lewis. 2008. Plasticity of macrophage function during tumor progression: regulation by distinct molecular mechanisms. J. Immunol. 180: 2011-2017.
27. Ye, R. D., F. Boulay, J. M. Wang, C. Dahlgren, C. Gerard, M. Parmentier, C. N. Serhan, and P. M. Murphy. 2009. International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol. Rev. 61: 119-161.
28. Tomhave, E. D., R. M. Richardson, J. R. Didsbury, L. Menard, R. Snyderman, and H. Ali. 1994. Cross-desensitization of receptors for peptide chemoattractants. Characterization of a new form of leukocyte regulation. J. Immunol. 153: 3267-3275.
29. Capra, V., M. R. Accomazzo, S. Ravasi, M. Parenti, M. Macchia, S. Nicosia, and G. E. Rovati. 2003. Involvement of prenylated proteins in calcium signaling induced by LTD4 in differentiated U937 cells. Prostaglandins Other Lipid Mediat. 71: 235-251. (Pubitemid 36929793)
30. Capra, V., S. Ravasi, M. R. Accomazzo, M. Parenti, and G. E. Rovati. 2004. CysLT1 signal transduction in differentiated U937 cells involves the activation of the small GTP-binding protein Ras. Biochem. Pharmacol. 67: 1569-1577.
31. DeLean, A., P. J. Munson, and D. Rodbard. 1978. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am. J. Physiol. 235: E97-E102.
32. Toullec, D., P. Pianetti, H. Coste, P. Bellevergue, T. Grand-Perret, M. Ajakane, V. Baudet, P. Boissin, E. Boursier, F. Loriolle, et al. 1991. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem. 266: 15771-15781. (Pubitemid 21907725)
33. Sakano, T., A. Fujie, T. Hamasaki, Y. Harada, H. Taniguchi, and K. Ueda. 1988. Intracellular Ca2+ mobilization in immature and more mature U937 induced to differentiate by dimethyl sulfoxide or phorbol myristate acetate. Cell. Immunol. 111: 390-397. (Pubitemid 18061823)
34. 4 induced calcium changes in U937 cells may utilize mechanisms additional to inositol phosphate production that are pertussis toxin insensitive but are blocked by phorbol myristate acetate. Cell. Signal. 2: 563-568.
35. Prossnitz, E. R., C. M. Kim, J. L. Benovic, and R. D. Ye. 1995. Phosphorylation of the N-formyl peptide receptor carboxyl terminus by the G protein-coupled receptor kinase, GRK2. J. Biol. Chem. 270: 1130-1137.
36. Willars, G. B., W. Muller-Esterl, and S. R. Nahorski. 1999. Receptor phosphorylation does not mediate cross talk between muscarinic M(3) and bradykinin B(2) receptors. Am. J. Physiol. 277: C859-C869.
37. Naik, S., C. K. Billington, R. M. Pascual, D. A. Deshpande, F. P. Stefano, T. A. Kohout, D. M. Eckman, J. L. Benovic, and R. B. Penn. 2005. Regulation of cysteinyl leukotriene type 1 receptor internalization and signaling. J. Biol. Chem. 280: 8722-8732. (Pubitemid 40409559)
38. Ferguson, S. S. 2007. Phosphorylation-independent attenuation of GPCR signalling. Trends Pharmacol. Sci. 28: 173-179.
39. Richardson, R. M., H. Ali, E. D. Tomhave, B. Haribabu, and R. Snyderman. 1995. Cross-desensitization of chemoattractant receptors occurs at multiple levels. Evidence for a role for inhibition of phospholipase C activity. J. Biol. Chem. 270: 27829-27833.
40. Honda, Z., T. Takano, N. Hirose, T. Suzuki, A. Muto, S. Kume, K. Mikoshiba, K. Itoh, and T. Shimizu. 1995. Gq pathway desensitizes chemotactic receptor-induced calcium signaling via inositol trisphosphate receptor down-regulation. J. Biol. Chem. 270: 4840-4844.
41. Sallese, M., S. Mariggio, E. D'Urbano, L. Iacovelli, and A. De Blasi. 2000. Selective regulation of Gq signaling by G protein-coupled receptor kinase 2: direct interaction of kinase N terminus with activated galphaq. Mol. Pharmacol. 57: 826-831.
42. Fields, T. A., and P. J. Casey. 1997. Signalling functions and biochemical properties of pertussis toxin-resistant G-proteins. Biochem. J. 321: 561-571.
43. Richardson, R. M., R. J. Marjoram, A. J. Barr, and R. Snyderman. 2001. RGS4 inhibits platelet-activating factor receptor phosphorylation and cellular responses. Biochemistry. 40: 3583-3588.
44. Woszczek, G., L. Y. Chen, S. Nagineni, S. Kern, J. Barb, P. J. Munson, C. Logun, R. L. Danner, and J. H. Shelhamer. 2008. Leukotriene D(4) induces gene expression in human monocytes through cysteinyl leukotriene type I receptor. J. Allergy Clin. Immunol. 121: 215-221.
45. 1 receptor. Nature. 399: 789-793.
46. Rovati, G. E., M. Baroffio, S. Citro, L. Brichetto, S. Ravasi, M. Milanese, E. Crimi, and V. Brusasco. 2006. Cysteinyl-leukotrienes in the regulation of beta2-adrenoceptor function: an in vitro model of asthma. Respir. Res. 7: 103.
47. Ali, H., S. Sozzani, I. Fisher, A. J. Barr, R. M. Richardson, B. Haribabu, and R. Snyderman. 1998. Differential regulation of formyl peptide and platelet-activating factor receptors. Role of phospholipase Cbeta3 phosphorylation by protein kinase A. J. Biol. Chem. 273: 11012-11016. (Pubitemid 28204943)
48. Gudermann, T., T. Schoneberg, and G. Schultz. 1997. Functional and structural complexity of signal transduction via G-protein-coupled receptors. Annu. Rev. Neurosci. 20: 399-427. (Pubitemid 27106388)
49. Hur, E. M., and K. T. Kim. 2002. G protein-coupled receptor signalling and cross-talk: achieving rapidity and specificity. Cell. Signal. 14: 397-405.
50. Maekawa, A., B. Balestrieri, K. F. Austen, and Y. Kanaoka. 2009. GPR17 is a negative regulator of the cysteinyl leukotriene 1 receptor response to leukotriene D4. Proc. Natl. Acad. Sci. USA. 106: 11685-11690.
51. Nielsen, C. K., J. I. Campbell, J. F. Ohd, M. Morgelin, K. Riesbeck, G. Landberg, and A. Sjolander. 2005. A novel localization of the G-protein-coupled CysLT1 receptor in the nucleus of colorectal adenocarcinoma cells. Cancer Res. 65: 732-742.
52. Heit, B., S. Tavener, E. Raharjo, and P. Kubes. 2002. An intracellular signaling hierarchy determines direction of migration in opposing chemotactic gradients. J. Cell Biol. 159: 91-102. (Pubitemid 35191521)